{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T11:30:57Z","timestamp":1788003057710,"version":"build-2784847793"},"reference-count":158,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>DDX3X is an RNA helicase with many functions in RNA metabolism such as mRNA translation, alternative pre-mRNA splicing and mRNA stability, but also plays a role as a regulator of transcription as well as in the Wnt\/beta-catenin- and Nf-\u03baB signaling pathways. The gene encoding DDX3X is located on the X-chromosome, but escapes X-inactivation. Hence females have two active copies and males only one. However, the Y chromosome contains the gene for the male DDX3 homologue, called <jats:italic>DDX3Y<\/jats:italic>, which has a very high sequence similarity and functional redundancy with DDX3X, but shows a more restricted protein expression pattern than DDX3X. High throughput sequencing of germinal center (GC)-derived B-cell malignancies such as Burkitt Lymphoma (BL) and Diffuse large B-cell lymphoma (DLBCL) samples showed a high frequency of loss-of-function (LOF) mutations in the <jats:italic>DDX3X<\/jats:italic> gene revealing several features that distinguish this gene from others. First, <jats:italic>DDX3X<\/jats:italic> mutations occur with high frequency particularly in those GC-derived B-cell lymphomas that also show translocations of the <jats:italic>c-MYC<\/jats:italic> proto-oncogene, which occurs in almost all BL and a subset of DLBCL. Second, <jats:italic>DDX3X<\/jats:italic> LOF mutations occur almost exclusively in males and is very rarely found in females. Third, mutations in the male homologue <jats:italic>DDX3Y<\/jats:italic> have never been found in any type of malignancy. Studies with human primary GC B cells from male donors showed that a loss of <jats:italic>DDX3X<\/jats:italic> function helps the initial process of B-cell lymphomagenesis by buffering the proteotoxic stress induced by c-MYC activation. However, full lymphomagenesis requires DDX3 activity since an upregulation of DDX3Y expression is invariably found in GC derived B-cell lymphoma with <jats:italic>DDX3X<\/jats:italic> LOF mutation. Other studies with male transgenic mice that lack <jats:italic>Ddx3x<\/jats:italic>, but constitutively express activated <jats:italic>c-Myc<\/jats:italic> transgenes in B cells and are therefore prone to develop B-cell malignancies, also showed upregulation of the DDX3Y protein expression during the process of lymphomagenesis. Since DDX3Y is not expressed in normal human cells, these data suggest that DDX3Y may represent a new cancer cell specific target to develop adjuvant therapies for male patients with BL and DLBCL and LOF mutations in the <jats:italic>DDX3X<\/jats:italic> gene.<\/jats:p>","DOI":"10.3389\/fonc.2023.1148936","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T14:47:14Z","timestamp":1679669234000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["The RNA helicase DDX3 and its role in c-MYC driven germinal center-derived B-cell lymphoma"],"prefix":"10.3389","volume":"13","author":[{"given":"Marion","family":"Lacroix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Beauchemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Khandanpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik","family":"M\u00f6r\u00f6y","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3154","article-title":"From unwinding to clamping - the DEAD box RNA helicase family","volume":"12","author":"Linder","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2013.03.007","article-title":"Looking back on the birth of DEAD-box RNA helicases","volume":"1829","author":"Linder","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1159\/000015022","article-title":"Assignment of a human putative RNA helicase gene, DDX3, to human X chromosome bands p11.3\u2013>p11.23","volume":"81","author":"Park","year":"1998","journal-title":"Cytogenet Cell Genet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1126\/science.278.5338.675","article-title":"Functional coherence of the human y chromosome","volume":"278","author":"Lahn","year":"1997","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1261\/rna.078926.121","article-title":"DDX3X and DDX3Y are redundant in protein synthesis","volume":"27","author":"Venkataramanan","year":"2021","journal-title":"RNA"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/190372a0","article-title":"Gene action in the X-chromosome of the mouse (Mus musculus l.)","volume":"190","author":"Lyon","year":"1961","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/35047580","article-title":"X-Chromosome inactivation: counting, choice and initiation","volume":"2","author":"Avner","year":"2001","journal-title":"Nat Rev Genet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genet-120116-024611","article-title":"X-Chromosome inactivation: A crossroads between chromosome architecture and gene regulation","volume":"52","author":"Galupa","year":"2018","journal-title":"Annu Rev Genet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nature03479","article-title":"X-Inactivation profile reveals extensive variability in X-linked gene expression in females","volume":"434","author":"Carrel","year":"2005","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1101\/gr.103200.109","article-title":"Global survey of escape from X inactivation by RNA-sequencing in mouse","volume":"20","author":"Yang","year":"2010","journal-title":"Genome Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nature13206","article-title":"Mammalian y chromosomes retain widely expressed dosage-sensitive regulators","volume":"508","author":"Bellott","year":"2014","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-013-1499-6","article-title":"The evolution of X chromosome inactivation in mammals: the demise of ohno\u2019s hypothesis","volume":"71","author":"Pessia","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.gene.2005.10.019","article-title":"The DEAD-box protein family of RNA helicases","volume":"367","author":"Cordin","year":"2006","journal-title":"Gene"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2010.03.011","article-title":"SF1 and SF2 helicases: family matters","volume":"20","author":"Fairman-Williams","year":"2010","journal-title":"Curr Opin Struct Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1165","article-title":"The role of the DEAD-box RNA helicase DDX3 in mRNA metabolism","volume":"4","author":"Soto-Rifo","year":"2013","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2007.06.050","article-title":"Crystal structure of conserved domains 1 and 2 of the human DEAD-box helicase DDX3X in complex with the mononucleotide AMP","volume":"372","author":"Hogbom","year":"2007","journal-title":"J Mol Biol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.700625","article-title":"Autoinhibitory interdomain interactions and subfamily-specific extensions redefine the catalytic core of the human DEAD-box protein DDX3","volume":"291","author":"Floor","year":"2016","journal-title":"J Biol Chem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2015.02.015","article-title":"Cancer-associated mutants of RNA helicase DDX3X are defective in RNA-stimulated ATP hydrolysis","volume":"427","author":"Epling","year":"2015","journal-title":"J Mol Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1016\/j.molcel.2022.04.022","article-title":"Sexually dimorphic RNA helicases DDX3X and DDX3Y differentially regulate RNA metabolism through phase separation","volume":"82","author":"Shen","year":"2022","journal-title":"Mol Cell"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2018.08.001","article-title":"Investigating nucleo-cytoplasmic shuttling of the human DEAD-box helicase DDX3","volume":"97","author":"Brennan","year":"2018","journal-title":"Eur J Cell Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2004.09.029","article-title":"Requirement of DDX3 DEAD box RNA helicase for HIV-1 rev-RRE export function","volume":"119","author":"Yedavalli","year":"2004","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210687","article-title":"Candidate tumor suppressor DDX3 RNA helicase specifically represses cap-dependent translation by acting as an eIF4E inhibitory protein","volume":"27","author":"Shih","year":"2008","journal-title":"Oncogene"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1999.9659","article-title":"Hepatitis c virus core protein interacts with a human DEAD box protein DDX3","volume":"257","author":"Owsianka","year":"1999","journal-title":"Virology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e07-12-1264","article-title":"The DEAD-box RNA helicase DDX3 associates with export messenger ribonucleoproteins as well as tip-associated protein and participates in translational control","volume":"19","author":"Lai","year":"2008","journal-title":"Mol Biol Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S140639","article-title":"Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer","volume":"10","author":"Heerma van Voss","year":"2017","journal-title":"Onco Targets Ther"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn454","article-title":"Human DDX3 functions in translation and interacts with the translation initiation factor eIF3","volume":"36","author":"Lee","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.33","article-title":"Oncogenic role of DDX3 in breast cancer biogenesis","volume":"27","author":"Botlagunta","year":"2008","journal-title":"Oncogene"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2008.126","article-title":"The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response","volume":"27","author":"Soulat","year":"2008","journal-title":"EMBO J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.molcel.2017.10.008","article-title":"R-ChIP using inactive RNase h reveals dynamic coupling of r-loops with transcriptional pausing at gene promoters","volume":"68","author":"Chen","year":"2017","journal-title":"Mol Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/onc.2017.308","article-title":"Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment","volume":"37","author":"Heerma van Voss","year":"2018","journal-title":"Oncogene"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/des047","article-title":"AZFa protein DDX3Y is differentially expressed in human male germ cells during development and in testicular tumours: new evidence for phenotypic plasticity of germ cells","volume":"27","author":"Gueler","year":"2012","journal-title":"Hum Reprod"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.912727","article-title":"A dual role of DDX3X in dsRNA-derived innate immune signaling","volume":"9","author":"Kwon","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab287","article-title":"DDX3 depletion represses translation of mRNAs with complex 5\u2019 UTRs","volume":"49","author":"Calviello","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12943-021-01325-7","article-title":"DDX3X: structure, physiologic functions and cancer","volume":"20","author":"Mo","year":"2021","journal-title":"Mol Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3390\/genes12101471","article-title":"DEAD-box RNA helicases and genome stability","volume":"12","author":"Cargill","year":"2021","journal-title":"Genes (Basel)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12943-015-0461-7","article-title":"DDX3, a potential target for cancer treatment","volume":"14","author":"Bol","year":"2015","journal-title":"Mol Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3109\/10409238.2014.931339","article-title":"The Ded1\/DDX3 subfamily of DEAD-box RNA helicases","volume":"49","author":"Sharma","year":"2014","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2014.00423","article-title":"Multiple functions of DDX3 RNA helicase in gene regulation, tumorigenesis, and viral infection","volume":"5","author":"Ariumi","year":"2014","journal-title":"Front Genet"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1042\/BST0390679","article-title":"Viruses and the human DEAD-box helicase DDX3: inhibition or exploitation","volume":"39","author":"Schroder","year":"2011","journal-title":"Biochem Soc Trans"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1845","article-title":"RNA Helicase DDX3: at the crossroad of viral replication and antiviral immunity","volume":"25","author":"Valiente-Echeverria","year":"2015","journal-title":"Rev Med Virol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"104994","DOI":"10.1016\/j.antiviral.2020.104994","article-title":"Targeting host DEAD-box RNA helicase DDX3X for treating viral infections","volume":"185","author":"Winnard","year":"2021","journal-title":"Antiviral Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.3390\/cells11101608","article-title":"DEAD\/H-box helicases in immunity, inflammation, cell differentiation, and cell death and disease","volume":"11","author":"Samir","year":"2022","journal-title":"Cells"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddh240","article-title":"The AZFa gene DBY (DDX3Y) is widely transcribed but the protein is limited to the male germ cells by translation control","volume":"13","author":"Ditton","year":"2004","journal-title":"Hum Mol Genet"},{"key":"B44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1365-2605.2010.01053.x","article-title":"Complex transcriptional control of the AZFa gene DDX3Y in human testis","volume":"34","author":"Rauschendorf","year":"2011","journal-title":"Int J Androl"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.2010.01079.x","article-title":"Translational control of the AZFa gene DDX3Y by 5\u2019UTR exon-T extension","volume":"34","author":"Jaroszynski","year":"2011","journal-title":"Int J Androl"},{"key":"B46","doi-asserted-by":"publisher","first-page":"14900","DOI":"10.1038\/s41598-020-71447-3","article-title":"Regulatory effects of the Uty\/Ddx3y locus on neighboring chromosome y genes and autosomal mRNA transcripts in adult mouse non-reproductive cells","volume":"10","author":"Deschepper","year":"2020","journal-title":"Sci Rep"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-2454","article-title":"The X-linked helicase DDX3X is required for lymphoid differentiation and MYC-driven lymphomagenesis","volume":"82","author":"Lacroix","year":"2022","journal-title":"Cancer Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1016\/j.molcel.2021.07.041","article-title":"Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis","volume":"81","author":"Gong","year":"2021","journal-title":"Mol Cell"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-096313","article-title":"DDX3Y encodes a class I MHC-restricted h-y antigen that is expressed in leukemic stem cells","volume":"111","author":"Rosinski","year":"2008","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2004.07.005","article-title":"Human DDX3Y, the y-encoded isoform of RNA helicase DDX3, rescues a hamster temperature-sensitive ET24 mutant cell line with a DDX3X mutation","volume":"300","author":"Sekiguchi","year":"2004","journal-title":"Exp Cell Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.devcel.2020.05.027","article-title":"DDX3X suppresses the susceptibility of hindbrain lineages to medulloblastoma","volume":"54","author":"Patmore","year":"2020","journal-title":"Dev Cell"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.78203.sa2","article-title":"Aberrant cortical development is driven by impaired cell cycle and translational control in a DDX3X syndrome model","volume":"11","author":"Hoye","year":"2022","journal-title":"Elife"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-18-0551","article-title":"Liver injury, and tumorigenesis: Consequences of DDX3X loss","volume":"17","author":"Chan","year":"2019","journal-title":"Mol Cancer Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007397","article-title":"The RNA helicase DDX3X is an essential mediator of innate antimicrobial immunity","volume":"14","author":"Szappanos","year":"2018","journal-title":"PloS Pathog"},{"key":"B55","doi-asserted-by":"publisher","first-page":"452086","DOI":"10.1101\/452086","article-title":"Ddx3x regulates b-cell development and light chain recombination in mice","author":"Liu","year":"2018","journal-title":"bioRxiv"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00755","article-title":"DEAD-box helicase DDX3X as a host target against emerging viruses: New insights for medicinal chemical approaches","volume":"65","author":"Brai","year":"2022","journal-title":"J Med Chem"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.2164\/jandrol.106.000471","article-title":"Structural characterization and expression studies of dby and its homologs in the mouse","volume":"27","author":"Vong","year":"2006","journal-title":"J Androl"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2819","article-title":"MYC as a regulator of ribosome biogenesis and protein synthesis","volume":"10","author":"van Riggelen","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1712408","article-title":"Myc\u2019s broad reach","volume":"22","author":"Eilers","year":"2008","journal-title":"Genes Dev"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-018-0650-z","article-title":"The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis","volume":"12","author":"Carroll","year":"2018","journal-title":"Front Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.06.012","article-title":"Synergy between PI3K signaling and MYC in burkitt lymphomagenesis","volume":"22","author":"Sander","year":"2012","journal-title":"Cancer Cell"},{"key":"B62","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.semcdb.2016.04.001","article-title":"Oncogenic KRAS signaling and YAP1\/beta-catenin: Similar cell cycle control in tumor initiation","volume":"58","author":"Nussinov","year":"2016","journal-title":"Semin Cell Dev Biol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-0787","article-title":"The myc and ras partnership in cancer: Indistinguishable alliance or contextual relationship","volume":"80","author":"Mahauad-Fernandez","year":"2020","journal-title":"Cancer Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0507","article-title":"MYC, metabolism, and cancer","volume":"5","author":"Stine","year":"2015","journal-title":"Cancer Discovery"},{"key":"B65","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-981-15-3532-1_4","article-title":"Germinal center reaction","volume":"1254","author":"Huang","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2017.03.007","article-title":"Deconstructing the germinal center, one cell at a time","volume":"45","author":"Dufaud","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"151421","DOI":"10.1016\/j.anndiagpath.2019.151421","article-title":"The life and death of the germinal center","volume":"44","author":"Gars","year":"2020","journal-title":"Ann Diagn Pathol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-120419-022408","article-title":"Germinal centers","volume":"40","author":"Victora","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.07.015","article-title":"The unique biology of germinal center b cells","volume":"54","author":"Young","year":"2021","journal-title":"Immunity"},{"key":"B70","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1146\/annurev.immunol.19.1.595","article-title":"B cell development pathways","volume":"19","author":"Hardy","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13176","article-title":"V(D)J recombination, somatic hypermutation and class switch recombination of immunoglobulins: mechanism and regulation","volume":"160","author":"Chi","year":"2020","journal-title":"Immunology"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1080\/10409238.2019.1659227","article-title":"Current insights into the mechanism of mammalian immunoglobulin class switch recombination","volume":"54","author":"Yu","year":"2019","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/bs.ai.2016.11.002","article-title":"Molecular mechanisms of somatic hypermutation and class switch recombination","volume":"133","author":"Methot","year":"2017","journal-title":"Adv Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.immuni.2019.07.001","article-title":"Class-switch recombination occurs infrequently in germinal centers","volume":"51","author":"Roco","year":"2019","journal-title":"Immunity"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12734","article-title":"MYC in germinal center-derived lymphomas: Mechanisms and therapeutic opportunities","volume":"288","author":"Bisso","year":"2019","journal-title":"Immunol Rev"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2418","article-title":"The cell-cycle regulator c-myc is essential for the formation and maintenance of germinal centers","volume":"13","author":"Calado","year":"2012","journal-title":"Nat Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abm0775","article-title":"Competition for refueling rather than cyclic reentry initiation evident in germinal centers","volume":"7","author":"Long","year":"2022","journal-title":"Sci Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2428","article-title":"The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry","volume":"13","author":"Dominguez-Sola","year":"2012","journal-title":"Nat Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3390\/cells8111365","article-title":"Germinal centre b cell functions and lymphomagenesis: Circuits involving MYC and MicroRNAs","volume":"8","author":"Robaina","year":"2019","journal-title":"Cells"},{"key":"B80","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.immuni.2019.06.013","article-title":"Protein amounts of the MYC transcription factor determine germinal center b cell division capacity","volume":"51","author":"Finkin","year":"2019","journal-title":"Immunity"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5312.596","article-title":"Repression of c-myc transcription by blimp-1, an inducer of terminal b cell differentiation","volume":"276","author":"Lin","year":"1997","journal-title":"Science"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200483","article-title":"Single-cell analysis of germinal-center b cells informs on lymphoma cell of origin and outcome","volume":"217","author":"Holmes","year":"2020","journal-title":"J Exp Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.3390\/ijms18091876","article-title":"The complex interplay between DNA injury and repair in enzymatically induced mutagenesis and DNA damage in b lymphocytes","volume":"18","author":"Bahjat","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12755","article-title":"Germinal center-derived lymphomas: The darkest side of humoral immunity","volume":"288","author":"Mlynarczyk","year":"2019","journal-title":"Immunol Rev"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61177-X","article-title":"Burkitt\u2019s lymphoma","volume":"379","author":"Molyneux","year":"2012","journal-title":"Lancet"},{"key":"B86","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/j.seminhematol.2015.01.009","article-title":"MYC alterations in diffuse large b-cell lymphomas","volume":"52","author":"Karube","year":"2015","journal-title":"Semin Hematol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11263","article-title":"High-grade b-cell lymphoma\/leukemia associated with t(14;18) and 8q24\/MYC rearrangement: a neoplasm of germinal center immunophenotype with poor prognosis","volume":"92","author":"Lin","year":"2007","journal-title":"Haematologica"},{"key":"B88","doi-asserted-by":"publisher","first-page":"a014282","DOI":"10.1101\/cshperspect.a014282","article-title":"Oncogenic mechanisms in burkitt lymphoma","volume":"4","author":"Schmitz","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B89","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"B90","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-1-0716-1476-1_6","article-title":"MYC analysis in cancer and evolution","volume":"2318","author":"Hartl","year":"2021","journal-title":"Methods Mol Biol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0903854106","article-title":"BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large b cell lymphoma","volume":"106","author":"Saito","year":"2009","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B92","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.3390\/ijms21124265","article-title":"Insights about MYC and apoptosis in b-lymphomagenesis: An update from murine models","volume":"21","author":"Vecchio","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2004.09.004","article-title":"Gender and age-related differences in burkitt lymphoma\u2013epidemiological and clinical data from the Netherlands","volume":"40","author":"Boerma","year":"2004","journal-title":"Eur J Cancer"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2025746","article-title":"Burkitt\u2019s lymphoma","volume":"387","author":"Roschewski","year":"2022","journal-title":"N Engl J Med"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24720","article-title":"Outcomes of adults with relapsed or refractory burkitt and high-grade b-cell leukemia\/lymphoma","volume":"92","author":"Short","year":"2017","journal-title":"Am J Hematol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-145128","article-title":"A prospective clinicopathologic study of dose-modified CODOX-M\/IVAC in patients with sporadic burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC\/NCRI LY10 trial)","volume":"112","author":"Mead","year":"2008","journal-title":"Blood"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30576","article-title":"Survival predictors of burkitt\u2019s lymphoma in children, adults and elderly in the united states during 2000-2013","volume":"140","author":"Mukhtar","year":"2017","journal-title":"Int J Cancer"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1159\/000253028","article-title":"Treatment-related burkitt\u2019s lymphoma: literature review and case report of successful treatment with rituximab monotherapy","volume":"122","author":"Nagasaki","year":"2009","journal-title":"Acta Haematol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pathol.2017.09.006","article-title":"Diffuse large b-cell lymphoma","volume":"50","author":"Li","year":"2018","journal-title":"Pathology"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2012.12.009","article-title":"Diffuse large b-cell lymphoma","volume":"87","author":"Martelli","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01285-3","article-title":"Treatment resistance in diffuse large b-cell lymphoma","volume":"35","author":"He","year":"2021","journal-title":"Leukemia"},{"key":"B102","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1182\/asheducation-2011.1.498","article-title":"Relapsed\/refractory diffuse large b-cell lymphoma","volume":"2011","author":"Friedberg","year":"2011","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2020.12.003","article-title":"Genomic characterisation of diffuse large b-cell lymphoma","volume":"53","author":"Harrington","year":"2021","journal-title":"Pathology"},{"key":"B104","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1385\/1-59259-936-2:015","article-title":"Molecular diagnosis of lymphoma: outcome prediction by gene expression profiling in diffuse large b-cell lymphoma","volume":"115","author":"Last","year":"2005","journal-title":"Methods Mol Med"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.14694\/EdBook_AM.2015.35.e449","article-title":"ABC, GCB, and double-hit diffuse Large b-cell lymphoma: Does subtype make a difference in therapy selection","author":"Nowakowski","year":"2015","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse Large b-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"key":"B107","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A probabilistic classification tool for genetic subtypes of diffuse Large b cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large b cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003535","article-title":"Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a haematological malignancy research network report","volume":"135","author":"Lacy","year":"2020","journal-title":"Blood"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.60.2383","article-title":"Prognostic significance of diffuse Large b-cell lymphoma cell of origin determined by digital gene expression in formalin-fixed paraffin-embedded tissue biopsies","volume":"33","author":"Scott","year":"2015","journal-title":"J Clin Oncol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.27610","article-title":"Clinical significance of BCL2, c-MYC, and BCL6 genetic abnormalities, Epstein-Barr virus infection, CD5 protein expression, germinal center b Cell\/Non-germinal center b-cell subtypes, Co-expression of MYC\/BCL2 proteins and Co-expression of MYC\/BCL2\/BCL6 proteins in diffuse Large b-cell lymphoma: A clinical and pathological correlation study of 120 patients","volume":"16","author":"Ting","year":"2019","journal-title":"Int J Med Sci"},{"key":"B112","article-title":"Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review","volume":"6","author":"Xu","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016534","article-title":"Genetic subgroups inform on pathobiology in adult and pediatric burkitt lymphoma","volume":"141","author":"Thomas","year":"2023","journal-title":"Blood"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30935-5","article-title":"Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large b-cell lymphoma (REMoDL-b): an open-label, randomised, phase 3 trial","volume":"20","author":"Davies","year":"2019","journal-title":"Lancet Oncol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.ccell.2021.10.006","article-title":"Effect of ibrutinib with r-CHOP chemotherapy in genetic subtypes of DLBCL","volume":"39","author":"Wilson","year":"2021","journal-title":"Cancer Cell"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3884","article-title":"Targeting b cell receptor signaling with ibrutinib in diffuse large b cell lymphoma","volume":"21","author":"Wilson","year":"2015","journal-title":"Nat Med"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2021.1953016","article-title":"Glofitamab CD20-TCB bispecific antibody","volume":"62","author":"Minson","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206913","article-title":"Glofitamab for relapsed or refractory diffuse Large b-cell lymphoma","volume":"387","author":"Dickinson","year":"2022","journal-title":"N Engl J Med"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2022000332","article-title":"Sequencing therapy in relapsed DLBCL","volume":"2022","author":"Flowers","year":"2022","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005158","article-title":"Distinct viral and mutational spectrum of endemic burkitt lymphoma","volume":"11","author":"Abate","year":"2015","journal-title":"PloS Pathog"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-16-0305","article-title":"Comprehensive transcriptome and mutational profiling of endemic burkitt lymphoma reveals EBV type-specific differences","volume":"15","author":"Kaymaz","year":"2017","journal-title":"Mol Cancer Res"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001880","article-title":"The whole-genome landscape of burkitt lymphoma subtypes","volume":"134","author":"Panea","year":"2019","journal-title":"Blood"},{"key":"B123","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1038\/s41467-022-31355-8","article-title":"Clinical relevance of molecular characteristics in burkitt lymphoma differs according to age","volume":"13","author":"Burkhardt","year":"2022","journal-title":"Nat Commun"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41467-019-08578-3","article-title":"Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic burkitt lymphoma","volume":"10","author":"Lopez","year":"2019","journal-title":"Nat Commun"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2469","article-title":"Recurrent mutation of the ID3 gene in burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing","volume":"44","author":"Richter","year":"2012","journal-title":"Nat Genet"},{"key":"B126","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.3390\/cancers14153820","article-title":"DEAD-box RNA helicases DDX3X and DDX5 as oncogenes or oncosuppressors: A network perspective","volume":"14","author":"Secchi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3358","article-title":"Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma","volume":"47","author":"Jiang","year":"2015","journal-title":"Nat Genet"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13211","article-title":"Identification of recurrent truncated DDX3X mutations in chronic lymphocytic leukaemia","volume":"169","author":"Ojha","year":"2015","journal-title":"Br J Haematol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"25996","DOI":"10.1038\/srep25996","article-title":"Cancer-associated DDX3X mutations drive stress granule assembly and impair global translation","volume":"6","author":"Valentin-Vega","year":"2016","journal-title":"Sci Rep"},{"key":"B130","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.neuron.2020.01.042","article-title":"Pathogenic DDX3X mutations impair RNA metabolism and neurogenesis during fetal cortical development","volume":"106","author":"Lennox","year":"2020","journal-title":"Neuron"},{"key":"B131","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12931-019-1174-z","article-title":"Roles of MYC-targeting long non-coding RNA MINCR in cell cycle regulation and apoptosis in non-small cell lung cancer","volume":"20","author":"Chen","year":"2019","journal-title":"Respir Res"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3249.LYMPHOMA20-PO-19","article-title":"Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis","volume":"81","author":"Gong","year":"2021","journal-title":"Cancer Cell"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-09-871418","article-title":"Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic burkitt lymphoma","volume":"133","author":"Grande","year":"2019","journal-title":"Blood"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-02-767335","article-title":"Adult high-grade b-cell lymphoma with burkitt lymphoma signature: genomic features and potential therapeutic targets","volume":"130","author":"Bouska","year":"2017","journal-title":"Blood"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-b-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular subtypes of diffuse large b-cell lymphoma arise by distinct genetic pathways","volume":"105","author":"Lenz","year":"2008","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0691-6","article-title":"Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC\/BCL2 double-hit","volume":"34","author":"Cucco","year":"2020","journal-title":"Leukemia"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015854","article-title":"Genomic profiling for clinical decision making in lymphoid neoplasms","volume":"140","author":"de Leval","year":"2022","journal-title":"Blood"},{"key":"B140","doi-asserted-by":"publisher","first-page":"5849","DOI":"10.3390\/cancers14235849","article-title":"Copy number alteration and mutational profile of high-grade b-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements, diffuse Large b-cell lymphoma with MYC-rearrangement, and diffuse Large b-cell lymphoma with MYC-cluster amplification","volume":"14","author":"Miyaoka","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08159.x","article-title":"Advances in the understanding of MYC-induced lymphomagenesis","volume":"149","author":"Klapproth","year":"2010","journal-title":"Br J Haematol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12943-021-01437-0","article-title":"DDX3X loss is an adverse prognostic marker in diffuse large b-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes","volume":"20","author":"Kizhakeyil","year":"2021","journal-title":"Mol Cancer"},{"key":"B144","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejca.2014.10.017","article-title":"Differential proteomic analysis of endemic and sporadic Epstein-Barr virus-positive and negative burkitt lymphoma","volume":"51","author":"El-Mallawany","year":"2015","journal-title":"Eur J Cancer"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-011-1011-z","article-title":"Genes that escape from X inactivation","volume":"130","author":"Berletch","year":"2011","journal-title":"Hum Genet"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3726","article-title":"Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias","volume":"49","author":"Dunford","year":"2017","journal-title":"Nat Genet"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2021.05.027","article-title":"Developmental and behavioral phenotypes in a mouse model of DDX3X syndrome","volume":"90","author":"Boitnott","year":"2021","journal-title":"Biol Psychiatry"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2021.09.009","article-title":"Sex, life, and death in MYC-driven lymphomagenesis","volume":"81","author":"Dang","year":"2021","journal-title":"Mol Cell"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1084\/jem.167.2.353","article-title":"The e mu-myc transgenic mouse. a model for high-incidence spontaneous lymphoma and leukemia of early b cells","volume":"167","author":"Harris","year":"1988","journal-title":"J Exp Med"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.8.1183","article-title":"Burkitt lymphoma in the mouse","volume":"192","author":"Kovalchuk","year":"2000","journal-title":"J Exp Med"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1038\/nature07449","article-title":"Suppression of myc oncogenic activity by ribosomal protein haploinsufficiency","volume":"456","author":"Barna","year":"2008","journal-title":"Nature"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-11-817296","article-title":"Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide","volume":"131","author":"Takahashi","year":"2018","journal-title":"Blood"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2022.2166830","article-title":"DDX3: a relevant therapeutic target for lymphoma","volume":"26","author":"Lacroix","year":"2022","journal-title":"Expert Opin Ther Targets"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac7041","article-title":"Identification and characterization of essential genes in the human genome","volume":"350","author":"Wang","year":"2015","journal-title":"Science"},{"key":"B155","doi-asserted-by":"publisher","first-page":"110636","DOI":"10.1016\/j.celrep.2022.110636","article-title":"Interrogation of cancer gene dependencies reveals paralog interactions of autosome and sex chromosome-encoded genes","volume":"39","author":"Koferle","year":"2022","journal-title":"Cell Rep"},{"key":"B156","doi-asserted-by":"publisher","first-page":"113137","DOI":"10.1016\/j.ejmech.2020.113137","article-title":"Targeting MYC: From understanding its biology to drug discovery","volume":"213","author":"Ross","year":"2021","journal-title":"Eur J Med Chem"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.4161\/rna.23312","article-title":"DEAD box RNA helicase functions in cancer","volume":"10","author":"Fuller-Pace","year":"2013","journal-title":"RNA Biol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019810","article-title":"A motif unique to the human DEAD-box protein DDX3 is important for nucleic acid binding, ATP hydrolysis, RNA\/DNA unwinding and HIV-1 replication","volume":"6","author":"Garbelli","year":"2011","journal-title":"PloS One"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1148936\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T14:47:19Z","timestamp":1679669239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1148936\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,24]]},"references-count":158,"alternative-id":["10.3389\/fonc.2023.1148936"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1148936","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,24]]},"article-number":"1148936"}}